Search results
NeuShen begins dosing for Phase I trial of schizophrenia treatment
Clinical Trials Arena via Yahoo Finance· 3 days agoNeuShen Therapeutics has dosed the first healthy volunteer in Australia, marking the start of a...
'Impressive' New Data on Novel Schizophrenia Hopeful KarXT
Medscape· 5 days agoThe novel investigational antipsychotic KarXT was effective and well tolerated in adults with ...
Teva Pharmaceutical’s stock climbs as schizophrenia treatment shows promise
Market Watch· 4 days agoTeva Pharmaceutical Industries stock jumped more than 6% early Wednesday after the company reported...
Teva Pharma's Turnaround Story: How A Key Win Helped It Clinch A Five-Year High
Investor's Business Daily· 4 days agoTeva stock surged to a five-year high Wednesday after the company beat first-quarter expectations...
Teva Stock Powers Ahead as Schizophrenia News Offsets Mixed Earnings
Barrons.com· 4 days agoShares of Teva Pharmaceutical Industries were climbing yet again on Wednesday, after the company...
Attorney for Doctor Who Drove Wife, Kids Off Cliff Says He's a 'Good Man' as Defense Seeks Mental...
People via Yahoo News· 1 day agoBentley reiterated, that if granted the treatment, his client would be placed under an intensive...
In Vivo Reactive Astrocyte Imaging in Patients With Schizophrenia Using [18F]THK5351
Journal of the American Medical Association· 4 days agoThis case-control study investigates the in vivo imaging of reactive astrocytes and their association with positive symptoms in patients with schizophrenia using validated ...
Teva, Medincell's schizophrenia drug succeeds in late-stage study
Reuters via Yahoo News· 4 days agoU.S.-listed shares of Teva were up 3.3% at $14.41 in premarket trading. The companies hope that the...
Teva and Medincell report positive data for TEV-‘749 in schizophrenia trial
Clinical Trials Arena via Yahoo Finance· 3 days ago“Schizophrenia is often a chronic life-long disease, but by using medication consistently, people...
...Initiates First-in-Human Trial of NS-136, a Novel Selective M4 Receptor Positive Allosteric...
NBC 17 Raleigh· 4 days agoM4 PAM presents a novel approach to treating schizophrenia, with potential benefits in alleviating negative symptoms and cognitive impairment.